SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-017544
Filing Date
2020-12-16
Accepted
2020-12-16 07:36:49
Documents
17
Period of Report
2020-12-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K espr-20201216.htm   iXBRL 8-K 34031
2 EX-99.1 swissapprovalpressrelease.htm EX-99.1 33376
8 image2.jpg GRAPHIC 9142
9 tm2026634d1_ex99-1img001a0a.jpg GRAPHIC 5932
  Complete submission text file 0001628280-20-017544.txt   240359

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20201216.xsd EX-101.SCH 2436
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20201216_cal.xml EX-101.CAL 722
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20201216_def.xml EX-101.DEF 1659
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20201216_lab.xml EX-101.LAB 24993
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20201216_pre.xml EX-101.PRE 13202
10 EXTRACTED XBRL INSTANCE DOCUMENT espr-20201216_htm.xml XML 10996
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 201391316
SIC: 2834 Pharmaceutical Preparations